Updates

BATM - Significantly higher sales and margins expected for H2

September 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

BATM’s latest H1 (sales of US$56.2m, operating profit US$1.6m, ebitda US$3.9m) are really only of academic interest given that shiny, new products are in the wings on both sides of its business and set to galvanise future sequential growth. BATM itself says it is “on track for significantly higher revenue in H2 19 along with improved margins.”The Bio-Medical side delivered sales of US$30.2m (+7% constant currency) and an operating profit of US$1.3m versus a loss of US$1.3m primarily due to a capital gain of US$3.2m from the part realisation of Ador.The distribution side currently dominates (81% of sales) and saw good growth in cancer diagnostic tests in Israel and has also received regulatory approval to off ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Dialight - Most of the heavy lifting looks complete

Xpediator

BATM (March 2021)

BATM - Trading ahead of expectations (August 2020)

BATM (June 2020)

BATM (April 2020)

BATM (March 2020)

BATM - First commercial agreement for Ador (February 2020)

BATM - Barnstorming H2 19 expected (January 2020)

BATM - Accelerates NFVâ€ˆdevelopments; buy (August 2019)

BATM - Trading ahead of market expectations (April 2019)

BATM (January 2019)

BATM - 5G play (November 2018)

BATM - Recovering but looks a long haul (April 2011)

BATM (June 2010)

BATM - Medical side growing fast (March 2010)

BATM (November 2009)

BATM (April 2009)

BATM (February 2009)

BATM - Shares surge to a new high (September 2008)

BATM - Trading well ahead of expectations (July 2008)

BATM (June 2008)

BATM - Shares surge to a six year high (March 2008)

BATM (October 2007)

BATM - Barnstorming 2008 seems likely (June 2007)

BATM - Nokia-Siemens merger could (March 2007)

BATM (January 2007)

BATM - Singapore office to add fast growth (October 2006)

BATM (July 2006)

BATM - Significant contract award (June 2006)

BATM (May 2006)

BATM (April 2006)

BATM (March 2006)

BATM - Wins biggest contract in entire history (December 2005)

BATM - Moves into profit (October 2005)

BATM - Raises presence in VoIP area (September 2005)

BATM - Shares break higher on profit expectation (August 2005)

BATM (April 2005)

BATM - Confirms Alcatel OEM agreement (November 2004)

BATM - About to move into profitability (October 2004)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

BATM - Significantly higher sales and margins expected for H2

September 2019

Related Articles

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW